nodes	percent_of_prediction	percent_of_DWPC	metapath
Pralatrexate—SLC19A1—tongue—epilepsy syndrome	0.0281	0.201	CbGeAlD
Pralatrexate—SLC19A1—head—epilepsy syndrome	0.00683	0.0488	CbGeAlD
Pralatrexate—SLC19A1—nervous system—epilepsy syndrome	0.00647	0.0463	CbGeAlD
Pralatrexate—SLC19A1—central nervous system—epilepsy syndrome	0.00623	0.0445	CbGeAlD
Pralatrexate—SLC19A1—cerebellum—epilepsy syndrome	0.00609	0.0435	CbGeAlD
Pralatrexate—FPGS—medulla oblongata—epilepsy syndrome	0.00574	0.041	CbGeAlD
Pralatrexate—FPGS—spinal cord—epilepsy syndrome	0.00512	0.0366	CbGeAlD
Pralatrexate—SLC19A1—brain—epilepsy syndrome	0.00495	0.0354	CbGeAlD
Pralatrexate—Pemetrexed—ATIC—epilepsy syndrome	0.00492	0.24	CrCbGaD
Pralatrexate—TYMS—telencephalon—epilepsy syndrome	0.00479	0.0342	CbGeAlD
Pralatrexate—DHFR—telencephalon—epilepsy syndrome	0.00474	0.0339	CbGeAlD
Pralatrexate—TYMS—L-Glutamine—Vigabatrin—epilepsy syndrome	0.00458	0.378	CbGdCrCtD
Pralatrexate—FPGS—head—epilepsy syndrome	0.00455	0.0325	CbGeAlD
Pralatrexate—FPGS—nervous system—epilepsy syndrome	0.00431	0.0308	CbGeAlD
Pralatrexate—FPGS—central nervous system—epilepsy syndrome	0.00415	0.0297	CbGeAlD
Pralatrexate—FPGS—cerebellum—epilepsy syndrome	0.00406	0.029	CbGeAlD
Pralatrexate—Tetrahydrofolic acid—ATIC—epilepsy syndrome	0.00397	0.194	CrCbGaD
Pralatrexate—DHFR—medulla oblongata—epilepsy syndrome	0.00373	0.0266	CbGeAlD
Pralatrexate—Methotrexate—FOLR1—epilepsy syndrome	0.00358	0.175	CrCbGaD
Pralatrexate—TYMS—midbrain—epilepsy syndrome	0.00344	0.0246	CbGeAlD
Pralatrexate—DHFR—midbrain—epilepsy syndrome	0.00341	0.0243	CbGeAlD
Pralatrexate—DHFR—spinal cord—epilepsy syndrome	0.00332	0.0238	CbGeAlD
Pralatrexate—FPGS—brain—epilepsy syndrome	0.0033	0.0236	CbGeAlD
Pralatrexate—DHFR—Niclosamide—Clonazepam—epilepsy syndrome	0.00312	0.258	CbGdCrCtD
Pralatrexate—TYMS—head—epilepsy syndrome	0.00298	0.0213	CbGeAlD
Pralatrexate—DHFR—head—epilepsy syndrome	0.00295	0.0211	CbGeAlD
Pralatrexate—TYMS—nervous system—epilepsy syndrome	0.00283	0.0202	CbGeAlD
Pralatrexate—DHFR—nervous system—epilepsy syndrome	0.0028	0.02	CbGeAlD
Pralatrexate—TYMS—central nervous system—epilepsy syndrome	0.00272	0.0195	CbGeAlD
Pralatrexate—Methotrexate—ATIC—epilepsy syndrome	0.00271	0.133	CrCbGaD
Pralatrexate—DHFR—central nervous system—epilepsy syndrome	0.0027	0.0193	CbGeAlD
Pralatrexate—TYMS—cerebellum—epilepsy syndrome	0.00266	0.019	CbGeAlD
Pralatrexate—DHFR—cerebellum—epilepsy syndrome	0.00264	0.0188	CbGeAlD
Pralatrexate—TYMS—brain—epilepsy syndrome	0.00216	0.0155	CbGeAlD
Pralatrexate—DHFR—brain—epilepsy syndrome	0.00214	0.0153	CbGeAlD
Pralatrexate—Leucovorin—ABCC2—epilepsy syndrome	0.00123	0.0601	CrCbGaD
Pralatrexate—Methotrexate—SLCO1A2—epilepsy syndrome	0.00114	0.0554	CrCbGaD
Pralatrexate—TYMS—Bortezomib—Lacosamide—epilepsy syndrome	0.000958	0.0791	CbGdCrCtD
Pralatrexate—TYMS—Nortriptyline—Oxcarbazepine—epilepsy syndrome	0.00088	0.0726	CbGdCrCtD
Pralatrexate—Rash—Clobazam—epilepsy syndrome	0.000804	0.00155	CcSEcCtD
Pralatrexate—Dermatitis—Clobazam—epilepsy syndrome	0.000803	0.00155	CcSEcCtD
Pralatrexate—Toxic epidermal necrolysis—Topiramate—epilepsy syndrome	0.000802	0.00155	CcSEcCtD
Pralatrexate—Thrombocytopenia—Carbamazepine—epilepsy syndrome	0.0008	0.00155	CcSEcCtD
Pralatrexate—Tachycardia—Carbamazepine—epilepsy syndrome	0.000798	0.00154	CcSEcCtD
Pralatrexate—Dyspnoea—Zonisamide—epilepsy syndrome	0.000798	0.00154	CcSEcCtD
Pralatrexate—Decreased appetite—Felbamate—epilepsy syndrome	0.000794	0.00153	CcSEcCtD
Pralatrexate—Tetrahydrofolic acid—ABCC2—epilepsy syndrome	0.000794	0.0388	CrCbGaD
Pralatrexate—Oedema—Lamotrigine—epilepsy syndrome	0.00079	0.00153	CcSEcCtD
Pralatrexate—Fatigue—Felbamate—epilepsy syndrome	0.000788	0.00152	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Vigabatrin—epilepsy syndrome	0.000784	0.00152	CcSEcCtD
Pralatrexate—Constipation—Felbamate—epilepsy syndrome	0.000781	0.00151	CcSEcCtD
Pralatrexate—Nausea—Lacosamide—epilepsy syndrome	0.00078	0.00151	CcSEcCtD
Pralatrexate—Anorexia—Carbamazepine—epilepsy syndrome	0.000779	0.00151	CcSEcCtD
Pralatrexate—Body temperature increased—Fosphenytoin—epilepsy syndrome	0.000778	0.0015	CcSEcCtD
Pralatrexate—Decreased appetite—Zonisamide—epilepsy syndrome	0.000778	0.0015	CcSEcCtD
Pralatrexate—Diarrhoea—Acetazolamide—epilepsy syndrome	0.000777	0.0015	CcSEcCtD
Pralatrexate—Thrombocytopenia—Lamotrigine—epilepsy syndrome	0.000774	0.00149	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Diazepam—epilepsy syndrome	0.000772	0.00149	CcSEcCtD
Pralatrexate—Fatigue—Zonisamide—epilepsy syndrome	0.000771	0.00149	CcSEcCtD
Pralatrexate—Tachycardia—Lamotrigine—epilepsy syndrome	0.000771	0.00149	CcSEcCtD
Pralatrexate—Epistaxis—Gabapentin—epilepsy syndrome	0.00077	0.00149	CcSEcCtD
Pralatrexate—Dyspnoea—Clonazepam—epilepsy syndrome	0.000769	0.00148	CcSEcCtD
Pralatrexate—Constipation—Zonisamide—epilepsy syndrome	0.000765	0.00148	CcSEcCtD
Pralatrexate—Dyspnoea—Phenytoin—epilepsy syndrome	0.000763	0.00147	CcSEcCtD
Pralatrexate—Dyspnoea—Oxcarbazepine—epilepsy syndrome	0.000759	0.00147	CcSEcCtD
Pralatrexate—Abdominal pain—Vigabatrin—epilepsy syndrome	0.000758	0.00146	CcSEcCtD
Pralatrexate—Body temperature increased—Vigabatrin—epilepsy syndrome	0.000758	0.00146	CcSEcCtD
Pralatrexate—Nausea—Clobazam—epilepsy syndrome	0.000757	0.00146	CcSEcCtD
Pralatrexate—Asthenia—Propofol—epilepsy syndrome	0.000757	0.00146	CcSEcCtD
Pralatrexate—Anorexia—Lamotrigine—epilepsy syndrome	0.000753	0.00145	CcSEcCtD
Pralatrexate—Decreased appetite—Clonazepam—epilepsy syndrome	0.000749	0.00145	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Felbamate—epilepsy syndrome	0.000747	0.00144	CcSEcCtD
Pralatrexate—Pruritus—Propofol—epilepsy syndrome	0.000747	0.00144	CcSEcCtD
Pralatrexate—Abdominal pain—Diazepam—epilepsy syndrome	0.000746	0.00144	CcSEcCtD
Pralatrexate—Decreased appetite—Phenytoin—epilepsy syndrome	0.000744	0.00144	CcSEcCtD
Pralatrexate—Back pain—Valproic Acid—epilepsy syndrome	0.000744	0.00144	CcSEcCtD
Pralatrexate—Fatigue—Clonazepam—epilepsy syndrome	0.000743	0.00144	CcSEcCtD
Pralatrexate—Asthenia—Midazolam—epilepsy syndrome	0.000741	0.00143	CcSEcCtD
Pralatrexate—Decreased appetite—Oxcarbazepine—epilepsy syndrome	0.00074	0.00143	CcSEcCtD
Pralatrexate—Fatigue—Phenytoin—epilepsy syndrome	0.000738	0.00143	CcSEcCtD
Pralatrexate—Constipation—Clonazepam—epilepsy syndrome	0.000737	0.00142	CcSEcCtD
Pralatrexate—Fatigue—Oxcarbazepine—epilepsy syndrome	0.000734	0.00142	CcSEcCtD
Pralatrexate—Constipation—Phenytoin—epilepsy syndrome	0.000732	0.00141	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Zonisamide—epilepsy syndrome	0.000731	0.00141	CcSEcCtD
Pralatrexate—Asthenia—Levetiracetam—epilepsy syndrome	0.000731	0.00141	CcSEcCtD
Pralatrexate—Pancytopenia—Topiramate—epilepsy syndrome	0.000731	0.00141	CcSEcCtD
Pralatrexate—Pruritus—Midazolam—epilepsy syndrome	0.00073	0.00141	CcSEcCtD
Pralatrexate—Dyspnoea—Carbamazepine—epilepsy syndrome	0.000729	0.00141	CcSEcCtD
Pralatrexate—Constipation—Oxcarbazepine—epilepsy syndrome	0.000728	0.00141	CcSEcCtD
Pralatrexate—Body temperature increased—Felbamate—epilepsy syndrome	0.000722	0.0014	CcSEcCtD
Pralatrexate—Abdominal pain—Felbamate—epilepsy syndrome	0.000722	0.0014	CcSEcCtD
Pralatrexate—Vomiting—Acetazolamide—epilepsy syndrome	0.000722	0.0014	CcSEcCtD
Pralatrexate—Diarrhoea—Propofol—epilepsy syndrome	0.000722	0.00139	CcSEcCtD
Pralatrexate—Pruritus—Levetiracetam—epilepsy syndrome	0.000721	0.00139	CcSEcCtD
Pralatrexate—Neutropenia—Topiramate—epilepsy syndrome	0.00072	0.00139	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Topiramate—epilepsy syndrome	0.000716	0.00138	CcSEcCtD
Pralatrexate—TYMS—Chlorprothixene—Midazolam—epilepsy syndrome	0.000711	0.0587	CbGdCrCtD
Pralatrexate—Anaemia—Valproic Acid—epilepsy syndrome	0.000711	0.00137	CcSEcCtD
Pralatrexate—Decreased appetite—Carbamazepine—epilepsy syndrome	0.000711	0.00137	CcSEcCtD
Pralatrexate—Body temperature increased—Zonisamide—epilepsy syndrome	0.000707	0.00137	CcSEcCtD
Pralatrexate—Abdominal pain—Zonisamide—epilepsy syndrome	0.000707	0.00137	CcSEcCtD
Pralatrexate—Asthenia—Fosphenytoin—epilepsy syndrome	0.000706	0.00136	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Clonazepam—epilepsy syndrome	0.000705	0.00136	CcSEcCtD
Pralatrexate—Fatigue—Carbamazepine—epilepsy syndrome	0.000705	0.00136	CcSEcCtD
Pralatrexate—Dyspnoea—Lamotrigine—epilepsy syndrome	0.000704	0.00136	CcSEcCtD
Pralatrexate—Folic Acid—ABCG2—epilepsy syndrome	0.000702	0.0343	CrCbGaD
Pralatrexate—Constipation—Carbamazepine—epilepsy syndrome	0.000699	0.00135	CcSEcCtD
Pralatrexate—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000698	0.00135	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	0.000697	0.00135	CcSEcCtD
Pralatrexate—Pruritus—Fosphenytoin—epilepsy syndrome	0.000696	0.00134	CcSEcCtD
Pralatrexate—Leukopenia—Valproic Acid—epilepsy syndrome	0.000689	0.00133	CcSEcCtD
Pralatrexate—Asthenia—Vigabatrin—epilepsy syndrome	0.000688	0.00133	CcSEcCtD
Pralatrexate—Decreased appetite—Lamotrigine—epilepsy syndrome	0.000687	0.00133	CcSEcCtD
Pralatrexate—Abdominal pain—Clonazepam—epilepsy syndrome	0.000682	0.00132	CcSEcCtD
Pralatrexate—Body temperature increased—Clonazepam—epilepsy syndrome	0.000682	0.00132	CcSEcCtD
Pralatrexate—Fatigue—Lamotrigine—epilepsy syndrome	0.000681	0.00132	CcSEcCtD
Pralatrexate—Pruritus—Vigabatrin—epilepsy syndrome	0.000679	0.00131	CcSEcCtD
Pralatrexate—Asthenia—Diazepam—epilepsy syndrome	0.000677	0.00131	CcSEcCtD
Pralatrexate—Body temperature increased—Phenytoin—epilepsy syndrome	0.000677	0.00131	CcSEcCtD
Pralatrexate—Constipation—Lamotrigine—epilepsy syndrome	0.000676	0.00131	CcSEcCtD
Pralatrexate—Nausea—Acetazolamide—epilepsy syndrome	0.000675	0.0013	CcSEcCtD
Pralatrexate—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000673	0.0013	CcSEcCtD
Pralatrexate—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.000673	0.0013	CcSEcCtD
Pralatrexate—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000673	0.0013	CcSEcCtD
Pralatrexate—Back pain—Pregabalin—epilepsy syndrome	0.000673	0.0013	CcSEcCtD
Pralatrexate—Cough—Valproic Acid—epilepsy syndrome	0.000671	0.0013	CcSEcCtD
Pralatrexate—Vomiting—Propofol—epilepsy syndrome	0.000671	0.0013	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.000668	0.00129	CcSEcCtD
Pralatrexate—Pruritus—Diazepam—epilepsy syndrome	0.000668	0.00129	CcSEcCtD
Pralatrexate—Rash—Propofol—epilepsy syndrome	0.000665	0.00129	CcSEcCtD
Pralatrexate—Dermatitis—Propofol—epilepsy syndrome	0.000665	0.00128	CcSEcCtD
Pralatrexate—TYMS—Niclosamide—Clonazepam—epilepsy syndrome	0.000664	0.0548	CbGdCrCtD
Pralatrexate—Vomiting—Midazolam—epilepsy syndrome	0.000656	0.00127	CcSEcCtD
Pralatrexate—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000656	0.00127	CcSEcCtD
Pralatrexate—Asthenia—Felbamate—epilepsy syndrome	0.000656	0.00127	CcSEcCtD
Pralatrexate—Rash—Midazolam—epilepsy syndrome	0.000651	0.00126	CcSEcCtD
Pralatrexate—Dermatitis—Midazolam—epilepsy syndrome	0.00065	0.00126	CcSEcCtD
Pralatrexate—Vomiting—Levetiracetam—epilepsy syndrome	0.000648	0.00125	CcSEcCtD
Pralatrexate—Epistaxis—Topiramate—epilepsy syndrome	0.000648	0.00125	CcSEcCtD
Pralatrexate—Pruritus—Felbamate—epilepsy syndrome	0.000647	0.00125	CcSEcCtD
Pralatrexate—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000646	0.00125	CcSEcCtD
Pralatrexate—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000646	0.00125	CcSEcCtD
Pralatrexate—Diarrhoea—Diazepam—epilepsy syndrome	0.000646	0.00125	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000646	0.00125	CcSEcCtD
Pralatrexate—Rash—Levetiracetam—epilepsy syndrome	0.000643	0.00124	CcSEcCtD
Pralatrexate—Anaemia—Pregabalin—epilepsy syndrome	0.000643	0.00124	CcSEcCtD
Pralatrexate—Dermatitis—Levetiracetam—epilepsy syndrome	0.000642	0.00124	CcSEcCtD
Pralatrexate—Asthenia—Zonisamide—epilepsy syndrome	0.000642	0.00124	CcSEcCtD
Pralatrexate—TYMS—Chlorprothixene—Diazepam—epilepsy syndrome	0.000634	0.0523	CbGdCrCtD
Pralatrexate—Pruritus—Zonisamide—epilepsy syndrome	0.000633	0.00122	CcSEcCtD
Pralatrexate—Oedema—Valproic Acid—epilepsy syndrome	0.000628	0.00121	CcSEcCtD
Pralatrexate—Nausea—Propofol—epilepsy syndrome	0.000627	0.00121	CcSEcCtD
Pralatrexate—Vomiting—Fosphenytoin—epilepsy syndrome	0.000626	0.00121	CcSEcCtD
Pralatrexate—Diarrhoea—Felbamate—epilepsy syndrome	0.000625	0.00121	CcSEcCtD
Pralatrexate—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000625	0.00121	CcSEcCtD
Pralatrexate—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000625	0.00121	CcSEcCtD
Pralatrexate—Leukopenia—Pregabalin—epilepsy syndrome	0.000622	0.0012	CcSEcCtD
Pralatrexate—Rash—Fosphenytoin—epilepsy syndrome	0.00062	0.0012	CcSEcCtD
Pralatrexate—Dermatitis—Fosphenytoin—epilepsy syndrome	0.00062	0.0012	CcSEcCtD
Pralatrexate—Asthenia—Clonazepam—epilepsy syndrome	0.000619	0.00119	CcSEcCtD
Pralatrexate—Back pain—Gabapentin—epilepsy syndrome	0.000617	0.00119	CcSEcCtD
Pralatrexate—Thrombocytopenia—Valproic Acid—epilepsy syndrome	0.000615	0.00119	CcSEcCtD
Pralatrexate—Asthenia—Phenytoin—epilepsy syndrome	0.000614	0.00119	CcSEcCtD
Pralatrexate—Nausea—Midazolam—epilepsy syndrome	0.000613	0.00118	CcSEcCtD
Pralatrexate—Tachycardia—Valproic Acid—epilepsy syndrome	0.000613	0.00118	CcSEcCtD
Pralatrexate—Diarrhoea—Zonisamide—epilepsy syndrome	0.000612	0.00118	CcSEcCtD
Pralatrexate—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000611	0.00118	CcSEcCtD
Pralatrexate—Pruritus—Clonazepam—epilepsy syndrome	0.00061	0.00118	CcSEcCtD
Pralatrexate—Vomiting—Vigabatrin—epilepsy syndrome	0.00061	0.00118	CcSEcCtD
Pralatrexate—Cough—Pregabalin—epilepsy syndrome	0.000607	0.00117	CcSEcCtD
Pralatrexate—Pruritus—Phenytoin—epilepsy syndrome	0.000606	0.00117	CcSEcCtD
Pralatrexate—Nausea—Levetiracetam—epilepsy syndrome	0.000606	0.00117	CcSEcCtD
Pralatrexate—Rash—Vigabatrin—epilepsy syndrome	0.000605	0.00117	CcSEcCtD
Pralatrexate—Dermatitis—Vigabatrin—epilepsy syndrome	0.000604	0.00117	CcSEcCtD
Pralatrexate—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000603	0.00116	CcSEcCtD
Pralatrexate—Vomiting—Diazepam—epilepsy syndrome	0.0006	0.00116	CcSEcCtD
Pralatrexate—Anorexia—Valproic Acid—epilepsy syndrome	0.000598	0.00116	CcSEcCtD
Pralatrexate—Rash—Diazepam—epilepsy syndrome	0.000595	0.00115	CcSEcCtD
Pralatrexate—Dermatitis—Diazepam—epilepsy syndrome	0.000595	0.00115	CcSEcCtD
Pralatrexate—Diarrhoea—Clonazepam—epilepsy syndrome	0.00059	0.00114	CcSEcCtD
Pralatrexate—Anaemia—Gabapentin—epilepsy syndrome	0.000589	0.00114	CcSEcCtD
Pralatrexate—Asthenia—Carbamazepine—epilepsy syndrome	0.000586	0.00113	CcSEcCtD
Pralatrexate—Diarrhoea—Phenytoin—epilepsy syndrome	0.000586	0.00113	CcSEcCtD
Pralatrexate—Nausea—Fosphenytoin—epilepsy syndrome	0.000584	0.00113	CcSEcCtD
Pralatrexate—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000583	0.00113	CcSEcCtD
Pralatrexate—Vomiting—Felbamate—epilepsy syndrome	0.000581	0.00112	CcSEcCtD
Pralatrexate—Pruritus—Carbamazepine—epilepsy syndrome	0.000578	0.00112	CcSEcCtD
Pralatrexate—Rash—Felbamate—epilepsy syndrome	0.000576	0.00111	CcSEcCtD
Pralatrexate—Dermatitis—Felbamate—epilepsy syndrome	0.000576	0.00111	CcSEcCtD
Pralatrexate—Leukopenia—Gabapentin—epilepsy syndrome	0.000571	0.0011	CcSEcCtD
Pralatrexate—Nausea—Vigabatrin—epilepsy syndrome	0.00057	0.0011	CcSEcCtD
Pralatrexate—TYMS—Chlorpromazine—Clobazam—epilepsy syndrome	0.000569	0.047	CbGdCrCtD
Pralatrexate—Vomiting—Zonisamide—epilepsy syndrome	0.000569	0.0011	CcSEcCtD
Pralatrexate—Oedema—Pregabalin—epilepsy syndrome	0.000568	0.0011	CcSEcCtD
Pralatrexate—Asthenia—Lamotrigine—epilepsy syndrome	0.000567	0.0011	CcSEcCtD
Pralatrexate—Rash—Zonisamide—epilepsy syndrome	0.000564	0.00109	CcSEcCtD
Pralatrexate—Dermatitis—Zonisamide—epilepsy syndrome	0.000564	0.00109	CcSEcCtD
Pralatrexate—Nausea—Diazepam—epilepsy syndrome	0.000561	0.00108	CcSEcCtD
Pralatrexate—Dyspnoea—Valproic Acid—epilepsy syndrome	0.00056	0.00108	CcSEcCtD
Pralatrexate—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000559	0.00108	CcSEcCtD
Pralatrexate—Pruritus—Lamotrigine—epilepsy syndrome	0.000559	0.00108	CcSEcCtD
Pralatrexate—Cough—Gabapentin—epilepsy syndrome	0.000556	0.00107	CcSEcCtD
Pralatrexate—Thrombocytopenia—Pregabalin—epilepsy syndrome	0.000556	0.00107	CcSEcCtD
Pralatrexate—Tachycardia—Pregabalin—epilepsy syndrome	0.000554	0.00107	CcSEcCtD
Pralatrexate—Vomiting—Clonazepam—epilepsy syndrome	0.000548	0.00106	CcSEcCtD
Pralatrexate—Decreased appetite—Valproic Acid—epilepsy syndrome	0.000546	0.00105	CcSEcCtD
Pralatrexate—Vomiting—Phenytoin—epilepsy syndrome	0.000544	0.00105	CcSEcCtD
Pralatrexate—Rash—Clonazepam—epilepsy syndrome	0.000544	0.00105	CcSEcCtD
Pralatrexate—Methotrexate—ABCC2—epilepsy syndrome	0.000543	0.0265	CrCbGaD
Pralatrexate—Dermatitis—Clonazepam—epilepsy syndrome	0.000543	0.00105	CcSEcCtD
Pralatrexate—Nausea—Felbamate—epilepsy syndrome	0.000543	0.00105	CcSEcCtD
Pralatrexate—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000542	0.00105	CcSEcCtD
Pralatrexate—Fatigue—Valproic Acid—epilepsy syndrome	0.000541	0.00105	CcSEcCtD
Pralatrexate—Anorexia—Pregabalin—epilepsy syndrome	0.000541	0.00105	CcSEcCtD
Pralatrexate—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000541	0.00104	CcSEcCtD
Pralatrexate—Rash—Phenytoin—epilepsy syndrome	0.00054	0.00104	CcSEcCtD
Pralatrexate—Dermatitis—Phenytoin—epilepsy syndrome	0.000539	0.00104	CcSEcCtD
Pralatrexate—Rash—Oxcarbazepine—epilepsy syndrome	0.000537	0.00104	CcSEcCtD
Pralatrexate—Constipation—Valproic Acid—epilepsy syndrome	0.000537	0.00104	CcSEcCtD
Pralatrexate—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000537	0.00104	CcSEcCtD
Pralatrexate—Nausea—Zonisamide—epilepsy syndrome	0.000531	0.00103	CcSEcCtD
Pralatrexate—Oedema—Gabapentin—epilepsy syndrome	0.00052	0.00101	CcSEcCtD
Pralatrexate—Vomiting—Carbamazepine—epilepsy syndrome	0.00052	0.001	CcSEcCtD
Pralatrexate—Back pain—Topiramate—epilepsy syndrome	0.000519	0.001	CcSEcCtD
Pralatrexate—Rash—Carbamazepine—epilepsy syndrome	0.000515	0.000996	CcSEcCtD
Pralatrexate—Dermatitis—Carbamazepine—epilepsy syndrome	0.000515	0.000995	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000513	0.000992	CcSEcCtD
Pralatrexate—Nausea—Clonazepam—epilepsy syndrome	0.000512	0.000989	CcSEcCtD
Pralatrexate—Thrombocytopenia—Gabapentin—epilepsy syndrome	0.00051	0.000984	CcSEcCtD
Pralatrexate—Nausea—Phenytoin—epilepsy syndrome	0.000509	0.000983	CcSEcCtD
Pralatrexate—Tachycardia—Gabapentin—epilepsy syndrome	0.000508	0.000981	CcSEcCtD
Pralatrexate—Dyspnoea—Pregabalin—epilepsy syndrome	0.000506	0.000978	CcSEcCtD
Pralatrexate—Nausea—Oxcarbazepine—epilepsy syndrome	0.000506	0.000977	CcSEcCtD
Pralatrexate—Vomiting—Lamotrigine—epilepsy syndrome	0.000502	0.00097	CcSEcCtD
Pralatrexate—Rash—Lamotrigine—epilepsy syndrome	0.000498	0.000962	CcSEcCtD
Pralatrexate—Dermatitis—Lamotrigine—epilepsy syndrome	0.000498	0.000961	CcSEcCtD
Pralatrexate—Body temperature increased—Valproic Acid—epilepsy syndrome	0.000496	0.000959	CcSEcCtD
Pralatrexate—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000496	0.000959	CcSEcCtD
Pralatrexate—Anorexia—Gabapentin—epilepsy syndrome	0.000496	0.000958	CcSEcCtD
Pralatrexate—Anaemia—Topiramate—epilepsy syndrome	0.000496	0.000958	CcSEcCtD
Pralatrexate—Decreased appetite—Pregabalin—epilepsy syndrome	0.000493	0.000953	CcSEcCtD
Pralatrexate—Fatigue—Pregabalin—epilepsy syndrome	0.000489	0.000945	CcSEcCtD
Pralatrexate—Nausea—Carbamazepine—epilepsy syndrome	0.000486	0.000938	CcSEcCtD
Pralatrexate—Constipation—Pregabalin—epilepsy syndrome	0.000485	0.000938	CcSEcCtD
Pralatrexate—Leukopenia—Topiramate—epilepsy syndrome	0.00048	0.000928	CcSEcCtD
Pralatrexate—Methotrexate—ABCG2—epilepsy syndrome	0.00048	0.0234	CrCbGaD
Pralatrexate—Nausea—Lamotrigine—epilepsy syndrome	0.000469	0.000907	CcSEcCtD
Pralatrexate—Cough—Topiramate—epilepsy syndrome	0.000468	0.000904	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000464	0.000897	CcSEcCtD
Pralatrexate—Dyspnoea—Gabapentin—epilepsy syndrome	0.000464	0.000896	CcSEcCtD
Pralatrexate—Decreased appetite—Gabapentin—epilepsy syndrome	0.000452	0.000874	CcSEcCtD
Pralatrexate—Asthenia—Valproic Acid—epilepsy syndrome	0.00045	0.00087	CcSEcCtD
Pralatrexate—Fatigue—Gabapentin—epilepsy syndrome	0.000449	0.000867	CcSEcCtD
Pralatrexate—Abdominal pain—Pregabalin—epilepsy syndrome	0.000449	0.000867	CcSEcCtD
Pralatrexate—Body temperature increased—Pregabalin—epilepsy syndrome	0.000449	0.000867	CcSEcCtD
Pralatrexate—Constipation—Gabapentin—epilepsy syndrome	0.000445	0.00086	CcSEcCtD
Pralatrexate—Pruritus—Valproic Acid—epilepsy syndrome	0.000444	0.000858	CcSEcCtD
Pralatrexate—Oedema—Topiramate—epilepsy syndrome	0.000438	0.000846	CcSEcCtD
Pralatrexate—Diarrhoea—Valproic Acid—epilepsy syndrome	0.00043	0.00083	CcSEcCtD
Pralatrexate—Thrombocytopenia—Topiramate—epilepsy syndrome	0.000429	0.000828	CcSEcCtD
Pralatrexate—Tachycardia—Topiramate—epilepsy syndrome	0.000427	0.000826	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.000426	0.000822	CcSEcCtD
Pralatrexate—Anorexia—Topiramate—epilepsy syndrome	0.000417	0.000806	CcSEcCtD
Pralatrexate—Body temperature increased—Gabapentin—epilepsy syndrome	0.000411	0.000795	CcSEcCtD
Pralatrexate—Abdominal pain—Gabapentin—epilepsy syndrome	0.000411	0.000795	CcSEcCtD
Pralatrexate—Asthenia—Pregabalin—epilepsy syndrome	0.000407	0.000787	CcSEcCtD
Pralatrexate—Pruritus—Pregabalin—epilepsy syndrome	0.000402	0.000776	CcSEcCtD
Pralatrexate—Vomiting—Valproic Acid—epilepsy syndrome	0.000399	0.000771	CcSEcCtD
Pralatrexate—Rash—Valproic Acid—epilepsy syndrome	0.000396	0.000765	CcSEcCtD
Pralatrexate—Dermatitis—Valproic Acid—epilepsy syndrome	0.000395	0.000764	CcSEcCtD
Pralatrexate—Dyspnoea—Topiramate—epilepsy syndrome	0.00039	0.000754	CcSEcCtD
Pralatrexate—Diarrhoea—Pregabalin—epilepsy syndrome	0.000388	0.00075	CcSEcCtD
Pralatrexate—Decreased appetite—Topiramate—epilepsy syndrome	0.000381	0.000735	CcSEcCtD
Pralatrexate—Fatigue—Topiramate—epilepsy syndrome	0.000377	0.000729	CcSEcCtD
Pralatrexate—Constipation—Topiramate—epilepsy syndrome	0.000374	0.000723	CcSEcCtD
Pralatrexate—Asthenia—Gabapentin—epilepsy syndrome	0.000373	0.000721	CcSEcCtD
Pralatrexate—Nausea—Valproic Acid—epilepsy syndrome	0.000373	0.00072	CcSEcCtD
Pralatrexate—Pruritus—Gabapentin—epilepsy syndrome	0.000368	0.000711	CcSEcCtD
Pralatrexate—Vomiting—Pregabalin—epilepsy syndrome	0.000361	0.000697	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Topiramate—epilepsy syndrome	0.000358	0.000692	CcSEcCtD
Pralatrexate—Rash—Pregabalin—epilepsy syndrome	0.000358	0.000691	CcSEcCtD
Pralatrexate—Dermatitis—Pregabalin—epilepsy syndrome	0.000358	0.000691	CcSEcCtD
Pralatrexate—Diarrhoea—Gabapentin—epilepsy syndrome	0.000356	0.000688	CcSEcCtD
Pralatrexate—Abdominal pain—Topiramate—epilepsy syndrome	0.000346	0.000669	CcSEcCtD
Pralatrexate—Body temperature increased—Topiramate—epilepsy syndrome	0.000346	0.000669	CcSEcCtD
Pralatrexate—Nausea—Pregabalin—epilepsy syndrome	0.000337	0.000651	CcSEcCtD
Pralatrexate—Vomiting—Gabapentin—epilepsy syndrome	0.000331	0.000639	CcSEcCtD
Pralatrexate—Rash—Gabapentin—epilepsy syndrome	0.000328	0.000634	CcSEcCtD
Pralatrexate—Dermatitis—Gabapentin—epilepsy syndrome	0.000328	0.000633	CcSEcCtD
Pralatrexate—Asthenia—Topiramate—epilepsy syndrome	0.000314	0.000607	CcSEcCtD
Pralatrexate—FPGS—Metabolism—CHRM3—epilepsy syndrome	0.000312	0.00101	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—KCNJ11—epilepsy syndrome	0.000312	0.00101	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—ABCB1—epilepsy syndrome	0.000311	0.001	CbGpPWpGaD
Pralatrexate—Pruritus—Topiramate—epilepsy syndrome	0.00031	0.000598	CcSEcCtD
Pralatrexate—Nausea—Gabapentin—epilepsy syndrome	0.000309	0.000597	CcSEcCtD
Pralatrexate—TYMS—Circadian rythm related genes—AVP—epilepsy syndrome	0.000308	0.000995	CbGpPWpGaD
Pralatrexate—DHFR—Folate Metabolism—TNF—epilepsy syndrome	0.000308	0.000995	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—SIRT1—epilepsy syndrome	0.000302	0.000976	CbGpPWpGaD
Pralatrexate—Diarrhoea—Topiramate—epilepsy syndrome	0.0003	0.000579	CcSEcCtD
Pralatrexate—SLC19A1—Metabolism—ABCG2—epilepsy syndrome	0.000299	0.000965	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—CYP2C19—epilepsy syndrome	0.000291	0.000941	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—CYP11A1—epilepsy syndrome	0.00029	0.000935	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—NHLRC1—epilepsy syndrome	0.000287	0.000926	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—EPM2A—epilepsy syndrome	0.000287	0.000926	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GAMT—epilepsy syndrome	0.000287	0.000926	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PNPO—epilepsy syndrome	0.000287	0.000926	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PFKL—epilepsy syndrome	0.000284	0.000917	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—SLC2A1—epilepsy syndrome	0.000282	0.000911	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—JUNB—epilepsy syndrome	0.00028	0.000905	CbGpPWpGaD
Pralatrexate—Vomiting—Topiramate—epilepsy syndrome	0.000278	0.000538	CcSEcCtD
Pralatrexate—SLC19A1—Disease—NOS1—epilepsy syndrome	0.000278	0.000898	CbGpPWpGaD
Pralatrexate—Rash—Topiramate—epilepsy syndrome	0.000276	0.000533	CcSEcCtD
Pralatrexate—Dermatitis—Topiramate—epilepsy syndrome	0.000276	0.000533	CcSEcCtD
Pralatrexate—TYMS—Metabolism—FAR1—epilepsy syndrome	0.000274	0.000884	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ADK—epilepsy syndrome	0.000274	0.000884	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—L2HGDH—epilepsy syndrome	0.000274	0.000884	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GLUD1—epilepsy syndrome	0.000274	0.000884	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CERS1—epilepsy syndrome	0.000274	0.000884	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PDXK—epilepsy syndrome	0.000274	0.000884	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—QDPR—epilepsy syndrome	0.000267	0.000861	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CA4—epilepsy syndrome	0.000267	0.000861	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—HBEGF—epilepsy syndrome	0.000265	0.000857	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—CYP2D6—epilepsy syndrome	0.000261	0.000844	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—AKT3—epilepsy syndrome	0.000261	0.000841	CbGpPWpGaD
Pralatrexate—Nausea—Topiramate—epilepsy syndrome	0.00026	0.000502	CcSEcCtD
Pralatrexate—DHFR—Disease—STX1B—epilepsy syndrome	0.00026	0.000838	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—ADAM10—epilepsy syndrome	0.000254	0.000821	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—ABCG2—epilepsy syndrome	0.000254	0.000821	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—COX3—epilepsy syndrome	0.000251	0.00081	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PNPO—epilepsy syndrome	0.00025	0.000808	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GAMT—epilepsy syndrome	0.00025	0.000808	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—NHLRC1—epilepsy syndrome	0.00025	0.000808	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—EPM2A—epilepsy syndrome	0.00025	0.000808	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—ADRA2A—epilepsy syndrome	0.000249	0.000803	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—CYP2C19—epilepsy syndrome	0.000248	0.0008	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—BCHE—epilepsy syndrome	0.000248	0.0008	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—CYP11A1—epilepsy syndrome	0.000246	0.000795	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CPSF4—epilepsy syndrome	0.000241	0.000779	CbGpPWpGaD
Pralatrexate—DHFR—Disease—GBE1—epilepsy syndrome	0.000241	0.000779	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PPP1R3C—epilepsy syndrome	0.000241	0.000779	CbGpPWpGaD
Pralatrexate—FPGS—Disease—SLC2A1—epilepsy syndrome	0.00024	0.000775	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	0.000239	0.000772	CbGpPWpGaD
Pralatrexate—FPGS—Disease—JUNB—epilepsy syndrome	0.000238	0.000769	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—SLCO1A2—epilepsy syndrome	0.000238	0.000768	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—KCNB1—epilepsy syndrome	0.000238	0.000768	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PFKL—epilepsy syndrome	0.000238	0.000768	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CACNA2D2—epilepsy syndrome	0.000238	0.000768	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—SLC6A8—epilepsy syndrome	0.000238	0.000768	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CDC42—epilepsy syndrome	0.000238	0.000767	CbGpPWpGaD
Pralatrexate—FPGS—Disease—NOS1—epilepsy syndrome	0.000237	0.000764	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—SLC2A1—epilepsy syndrome	0.000236	0.000763	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PLCB1—epilepsy syndrome	0.000234	0.000755	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—TH—epilepsy syndrome	0.000233	0.000752	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CA4—epilepsy syndrome	0.000233	0.000752	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—QDPR—epilepsy syndrome	0.000233	0.000752	CbGpPWpGaD
Pralatrexate—FPGS—Disease—HBEGF—epilepsy syndrome	0.000226	0.000728	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—CYP2D6—epilepsy syndrome	0.000222	0.000717	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—NOS2—epilepsy syndrome	0.000222	0.000717	CbGpPWpGaD
Pralatrexate—FPGS—Disease—AKT3—epilepsy syndrome	0.000222	0.000715	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—COX3—epilepsy syndrome	0.000219	0.000707	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—HES1—epilepsy syndrome	0.000218	0.000702	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ATIC—epilepsy syndrome	0.000218	0.000702	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—UPB1—epilepsy syndrome	0.000218	0.000702	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—NEU1—epilepsy syndrome	0.000218	0.000702	CbGpPWpGaD
Pralatrexate—FPGS—Disease—ADAM10—epilepsy syndrome	0.000216	0.000698	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—FYN—epilepsy syndrome	0.000212	0.000683	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—ADRA2A—epilepsy syndrome	0.000212	0.000683	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—H2AFX—epilepsy syndrome	0.000211	0.000681	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—BCHE—epilepsy syndrome	0.000211	0.00068	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—HSD17B4—epilepsy syndrome	0.000209	0.000676	CbGpPWpGaD
Pralatrexate—Methotrexate—ALB—epilepsy syndrome	0.000209	0.0102	CrCbGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	0.000209	0.000674	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—KCNB1—epilepsy syndrome	0.000208	0.00067	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—SLCO1A2—epilepsy syndrome	0.000208	0.00067	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PFKL—epilepsy syndrome	0.000208	0.00067	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CACNA2D2—epilepsy syndrome	0.000208	0.00067	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—SLC6A8—epilepsy syndrome	0.000208	0.00067	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—APEX1—epilepsy syndrome	0.000204	0.000659	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—YWHAZ—epilepsy syndrome	0.000203	0.000657	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GBE1—epilepsy syndrome	0.000202	0.000653	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PPP1R3C—epilepsy syndrome	0.000202	0.000653	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CDC42—epilepsy syndrome	0.000202	0.000652	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—SLC2A1—epilepsy syndrome	0.000201	0.000649	CbGpPWpGaD
Pralatrexate—DHFR—Disease—ST3GAL3—epilepsy syndrome	0.000201	0.000649	CbGpPWpGaD
Pralatrexate—Methotrexate—ABCB1—epilepsy syndrome	0.0002	0.00975	CrCbGaD
Pralatrexate—FPGS—Metabolism—PLCB1—epilepsy syndrome	0.000199	0.000642	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—TH—epilepsy syndrome	0.000198	0.000639	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CCR5—epilepsy syndrome	0.000196	0.000632	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—HMOX1—epilepsy syndrome	0.000194	0.000628	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—CAT—epilepsy syndrome	0.000192	0.000619	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ASAH1—epilepsy syndrome	0.00019	0.000614	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—NEU1—epilepsy syndrome	0.00019	0.000613	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ATIC—epilepsy syndrome	0.00019	0.000613	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—UPB1—epilepsy syndrome	0.00019	0.000613	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	0.000189	0.000609	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—ABCB1—epilepsy syndrome	0.000187	0.000602	CbGpPWpGaD
Pralatrexate—FPGS—Disease—HES1—epilepsy syndrome	0.000185	0.000597	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—STXBP1—epilepsy syndrome	0.000185	0.000597	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—HSD17B4—epilepsy syndrome	0.000183	0.00059	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—APEX1—epilepsy syndrome	0.000183	0.000589	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—TSC2—epilepsy syndrome	0.000182	0.000587	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—NT5E—epilepsy syndrome	0.00018	0.000582	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ALAD—epilepsy syndrome	0.00018	0.000582	CbGpPWpGaD
Pralatrexate—FPGS—Disease—FYN—epilepsy syndrome	0.00018	0.000581	CbGpPWpGaD
Pralatrexate—FPGS—Disease—H2AFX—epilepsy syndrome	0.000179	0.000579	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	0.000179	0.000578	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—APEX1—epilepsy syndrome	0.000178	0.000575	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—APOE—epilepsy syndrome	0.000178	0.000575	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PPP1R3C—epilepsy syndrome	0.000176	0.00057	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GBE1—epilepsy syndrome	0.000176	0.00057	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—GPX1—epilepsy syndrome	0.000174	0.00056	CbGpPWpGaD
Pralatrexate—FPGS—Disease—YWHAZ—epilepsy syndrome	0.000173	0.000558	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CACNA1A—epilepsy syndrome	0.000172	0.000555	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ALDH7A1—epilepsy syndrome	0.000172	0.000555	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	0.00017	0.00055	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ST3GAL3—epilepsy syndrome	0.000168	0.000543	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—IL6ST—epilepsy syndrome	0.000167	0.00054	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CCR5—epilepsy syndrome	0.000166	0.000537	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ASAH1—epilepsy syndrome	0.000166	0.000536	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—NOS2—epilepsy syndrome	0.000166	0.000535	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—HMOX1—epilepsy syndrome	0.000165	0.000534	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ADSL—epilepsy syndrome	0.000165	0.000532	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—H2AFX—epilepsy syndrome	0.000163	0.000527	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—CAT—epilepsy syndrome	0.000163	0.000527	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GLUL—epilepsy syndrome	0.000162	0.000522	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—STXBP1—epilepsy syndrome	0.000161	0.000521	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—APEX1—epilepsy syndrome	0.000159	0.000514	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—ABCB1—epilepsy syndrome	0.000159	0.000512	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CACNA1D—epilepsy syndrome	0.000159	0.000512	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	0.000158	0.00051	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—NT5E—epilepsy syndrome	0.000157	0.000508	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ALAD—epilepsy syndrome	0.000157	0.000508	CbGpPWpGaD
Pralatrexate—FPGS—Disease—TSC2—epilepsy syndrome	0.000155	0.000499	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	0.000154	0.000495	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—AGT—epilepsy syndrome	0.000152	0.000491	CbGpPWpGaD
Pralatrexate—FPGS—Disease—APOE—epilepsy syndrome	0.000151	0.000489	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ALDH7A1—epilepsy syndrome	0.00015	0.000484	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CACNA1A—epilepsy syndrome	0.00015	0.000484	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—APOE—epilepsy syndrome	0.000149	0.000481	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—TXNRD1—epilepsy syndrome	0.000148	0.000479	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—GPX1—epilepsy syndrome	0.000148	0.000476	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—JUN—epilepsy syndrome	0.000147	0.000476	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ST3GAL3—epilepsy syndrome	0.000147	0.000474	CbGpPWpGaD
Pralatrexate—DHFR—Disease—EIF2AK2—epilepsy syndrome	0.000146	0.000472	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—H2AFX—epilepsy syndrome	0.000146	0.000471	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—AQP1—epilepsy syndrome	0.000144	0.000465	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ADSL—epilepsy syndrome	0.000144	0.000464	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—H2AFX—epilepsy syndrome	0.000142	0.00046	CbGpPWpGaD
Pralatrexate—FPGS—Disease—IL6ST—epilepsy syndrome	0.000142	0.000459	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GLUL—epilepsy syndrome	0.000141	0.000455	CbGpPWpGaD
Pralatrexate—FPGS—Disease—NOS2—epilepsy syndrome	0.000141	0.000455	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CACNA1D—epilepsy syndrome	0.000138	0.000447	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	0.000138	0.000444	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PPIA—epilepsy syndrome	0.000135	0.000437	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—FGF2—epilepsy syndrome	0.000135	0.000436	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	0.000134	0.000433	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—KCNJ11—epilepsy syndrome	0.00013	0.000421	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CHRM3—epilepsy syndrome	0.00013	0.000421	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—PRKCB—epilepsy syndrome	0.00013	0.00042	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—TXNRD1—epilepsy syndrome	0.00013	0.000418	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—AGT—epilepsy syndrome	0.000129	0.000418	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—POMC—epilepsy syndrome	0.000128	0.000413	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—H2AFX—epilepsy syndrome	0.000127	0.000411	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—APOE—epilepsy syndrome	0.000127	0.000409	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—AQP1—epilepsy syndrome	0.000126	0.000406	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—MTOR—epilepsy syndrome	0.000123	0.000397	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—PTGS2—epilepsy syndrome	0.000122	0.000394	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—ATM—epilepsy syndrome	0.000119	0.000383	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—ALB—epilepsy syndrome	0.000117	0.000377	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—PRKCB—epilepsy syndrome	0.000116	0.000375	CbGpPWpGaD
Pralatrexate—FPGS—Disease—FGF2—epilepsy syndrome	0.000115	0.000371	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	0.000115	0.000371	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CHRM3—epilepsy syndrome	0.000114	0.000367	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—KCNJ11—epilepsy syndrome	0.000114	0.000367	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—PRKCB—epilepsy syndrome	0.000113	0.000366	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—POMC—epilepsy syndrome	0.000109	0.000352	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ABCG2—epilepsy syndrome	0.000106	0.000343	CbGpPWpGaD
Pralatrexate—FPGS—Disease—MTOR—epilepsy syndrome	0.000105	0.000338	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PTGS2—epilepsy syndrome	0.000104	0.000335	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—ATM—epilepsy syndrome	0.000104	0.000334	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CYP2C19—epilepsy syndrome	0.000104	0.000334	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CYP11A1—epilepsy syndrome	0.000103	0.000332	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PTGS2—epilepsy syndrome	0.000102	0.00033	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—PRKCB—epilepsy syndrome	0.000101	0.000327	CbGpPWpGaD
Pralatrexate—DHFR—Disease—SLC2A1—epilepsy syndrome	0.0001	0.000324	CbGpPWpGaD
Pralatrexate—DHFR—Disease—JUNB—epilepsy syndrome	9.95e-05	0.000321	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—ALB—epilepsy syndrome	9.93e-05	0.00032	CbGpPWpGaD
Pralatrexate—DHFR—Disease—NOS1—epilepsy syndrome	9.88e-05	0.000319	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—SRC—epilepsy syndrome	9.87e-05	0.000318	CbGpPWpGaD
Pralatrexate—DHFR—Disease—HBEGF—epilepsy syndrome	9.43e-05	0.000304	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CYP2D6—epilepsy syndrome	9.29e-05	0.0003	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ABCG2—epilepsy syndrome	9.27e-05	0.000299	CbGpPWpGaD
Pralatrexate—DHFR—Disease—AKT3—epilepsy syndrome	9.25e-05	0.000299	CbGpPWpGaD
Pralatrexate—DHFR—Disease—ADAM10—epilepsy syndrome	9.04e-05	0.000292	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CYP2C19—epilepsy syndrome	9.03e-05	0.000292	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CYP11A1—epilepsy syndrome	8.98e-05	0.00029	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ADRA2A—epilepsy syndrome	8.84e-05	0.000285	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—BCHE—epilepsy syndrome	8.8e-05	0.000284	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PTGS2—epilepsy syndrome	8.69e-05	0.00028	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	8.56e-05	0.000276	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CDC42—epilepsy syndrome	8.44e-05	0.000273	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—SLC2A1—epilepsy syndrome	8.4e-05	0.000271	CbGpPWpGaD
Pralatrexate—FPGS—Disease—SRC—epilepsy syndrome	8.39e-05	0.000271	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PLCB1—epilepsy syndrome	8.31e-05	0.000268	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—TH—epilepsy syndrome	8.28e-05	0.000267	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CYP2D6—epilepsy syndrome	8.1e-05	0.000262	CbGpPWpGaD
Pralatrexate—DHFR—Disease—HES1—epilepsy syndrome	7.73e-05	0.000249	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ADRA2A—epilepsy syndrome	7.71e-05	0.000249	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—BCHE—epilepsy syndrome	7.68e-05	0.000248	CbGpPWpGaD
Pralatrexate—DHFR—Disease—FYN—epilepsy syndrome	7.52e-05	0.000243	CbGpPWpGaD
Pralatrexate—DHFR—Disease—H2AFX—epilepsy syndrome	7.49e-05	0.000242	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—SLC2A1—epilepsy syndrome	7.33e-05	0.000237	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PLCB1—epilepsy syndrome	7.25e-05	0.000234	CbGpPWpGaD
Pralatrexate—DHFR—Disease—YWHAZ—epilepsy syndrome	7.23e-05	0.000233	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—TH—epilepsy syndrome	7.22e-05	0.000233	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CCR5—epilepsy syndrome	6.95e-05	0.000224	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—HMOX1—epilepsy syndrome	6.91e-05	0.000223	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CAT—epilepsy syndrome	6.82e-05	0.00022	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ABCB1—epilepsy syndrome	6.63e-05	0.000214	CbGpPWpGaD
Pralatrexate—DHFR—Disease—TSC2—epilepsy syndrome	6.46e-05	0.000209	CbGpPWpGaD
Pralatrexate—DHFR—Disease—APOE—epilepsy syndrome	6.32e-05	0.000204	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GPX1—epilepsy syndrome	6.16e-05	0.000199	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—AKT1—epilepsy syndrome	6.13e-05	0.000198	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—HMOX1—epilepsy syndrome	6.03e-05	0.000195	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CAT—epilepsy syndrome	5.95e-05	0.000192	CbGpPWpGaD
Pralatrexate—DHFR—Disease—IL6ST—epilepsy syndrome	5.94e-05	0.000192	CbGpPWpGaD
Pralatrexate—DHFR—Disease—NOS2—epilepsy syndrome	5.89e-05	0.00019	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ABCB1—epilepsy syndrome	5.79e-05	0.000187	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—AGT—epilepsy syndrome	5.41e-05	0.000174	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GPX1—epilepsy syndrome	5.38e-05	0.000174	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—APOE—epilepsy syndrome	5.3e-05	0.000171	CbGpPWpGaD
Pralatrexate—FPGS—Disease—AKT1—epilepsy syndrome	5.21e-05	0.000168	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—AKT1—epilepsy syndrome	5.13e-05	0.000166	CbGpPWpGaD
Pralatrexate—DHFR—Disease—FGF2—epilepsy syndrome	4.8e-05	0.000155	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—AGT—epilepsy syndrome	4.72e-05	0.000152	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—APOE—epilepsy syndrome	4.62e-05	0.000149	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—POMC—epilepsy syndrome	4.55e-05	0.000147	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MTOR—epilepsy syndrome	4.37e-05	0.000141	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—AKT1—epilepsy syndrome	4.37e-05	0.000141	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PTGS2—epilepsy syndrome	4.33e-05	0.00014	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ALB—epilepsy syndrome	4.15e-05	0.000134	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—POMC—epilepsy syndrome	3.97e-05	0.000128	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PTGS2—epilepsy syndrome	3.63e-05	0.000117	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ALB—epilepsy syndrome	3.62e-05	0.000117	CbGpPWpGaD
Pralatrexate—DHFR—Disease—SRC—epilepsy syndrome	3.5e-05	0.000113	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PTGS2—epilepsy syndrome	3.17e-05	0.000102	CbGpPWpGaD
Pralatrexate—DHFR—Disease—AKT1—epilepsy syndrome	2.18e-05	7.03e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—AKT1—epilepsy syndrome	1.82e-05	5.89e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—AKT1—epilepsy syndrome	1.59e-05	5.14e-05	CbGpPWpGaD
